Management ofPseudomonas aeruginosainfection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin

Clinical applications of pulmonary delivery of antibiotics

(2015) Patrick A. Flume et al.   ADVANCED DRUG DELIVERY REVIEWS

Inhaled antibiotics: dry or wet?

(2014) H. A. W. M. Tiddens et al.   EUROPEAN RESPIRATORY JOURNAL

Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review

(2014) A. M. Brodt et al.   EUROPEAN RESPIRATORY JOURNAL

Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS

(2014) Dorota Sands et al.   Journal of Cystic Fibrosis

Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis

(2014) Henryk Mazurek et al.   PEDIATRIC PULMONOLOGY

Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

(2013) Kate McKeage   DRUGS

Inhaled antibiotics for the treatment of chronic bronchopulmonaryPseudomonas aeruginosainfection in cystic fibrosis: systematic review of randomised controlled trials

(2013) Luis Máiz et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis

(2013) Sanja Stanojevic et al.   Journal of Cystic Fibrosis

Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

(2013) J P Clancy et al.   THORAX

Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment ofPseudomonas aeruginosabiofilm infections

(2012) Oana Ciofu et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

(2012) Gerd Döring et al.   Journal of Cystic Fibrosis

A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis

(2012) Kavi J. Littlewood et al.   Journal of Cystic Fibrosis

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

(2012) Margaret Rosenfeld et al.   Journal of Cystic Fibrosis

Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms

(2012) Warren E. Regelmann et al.   PEDIATRIC PULMONOLOGY

Decade-long bacterial community dynamics in cystic fibrosis airways

(2012) J. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

(2012) Antje Schuster et al.   THORAX

Early antibiotic treatment forPseudomonas aeruginosaeradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols

(2012) Giovanni Taccetti et al.   THORAX

Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa

(2011) David E. Geller et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection

(2011) Bruce C. Trapnell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects

(2011) David E. Geller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis

(2011) Miriam M. Treggiari   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis

(2011) Niels Høiby   BMC Medicine

Cystic Fibrosis Transmembrane Conductance Regulator Intracellular Processing, Trafficking, and Opportunities for Mutation-Specific Treatment

(2011) Mark P. Rogan et al.   CHEST

Colistin: new lessons on an old antibiotic

(2011) D. Yahav et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

(2011) D. Bilton et al.   Journal of Cystic Fibrosis

Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report

(2011) T. Pressler et al.   Journal of Cystic Fibrosis

Approach to treating cystic fibrosis pulmonary exacerbations varies widely across us CF care centers

(2011) Nathan C. Kraynack et al.   PEDIATRIC PULMONOLOGY

Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis

(2010) Elliott C. Dasenbrook   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

(2010) Michael W. Konstan et al.   Journal of Cystic Fibrosis

Return of FEV1after pulmonary exacerbation in children with cystic fibrosis

(2010) Don B. Sanders et al.   PEDIATRIC PULMONOLOGY

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

(2010) Christopher M. Oermann et al.   PEDIATRIC PULMONOLOGY

Cystic Fibrosis Pulmonary Guidelines

(2009) Patrick A. Flume et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

(2009) O. O. Okusanya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

(2009) George Z. Retsch-Bogart et al.   CHEST

Colistin in the 21st century

(2009) Roger L Nation et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers

(2009) Jeffry Weers et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review

(2009) Felix Ratjen et al.   Journal of Cystic Fibrosis

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

(2009) F. Ratjen et al.   THORAX

Eradication of early Pseudomonas infection in cystic fibrosis

(2009) TWR Lee   Chronic Respiratory Disease

Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis

(2008) Karen S. McCoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Characterization of Nebulized Liposomal Amikacin (Arikace™) as a Function of Droplet Size

(2008) Zhili Li et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections

(2008) P. Meers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY